CRT 2026
Artificial Intelligence and Digital Health
Jonathan Schwartz, MD
Enterprise Director of Cardiovascular Innovation, Structural Interventional Cardiologist
Sanger Heart & Vascular Institute, North Carolina, United States
Disclosure(s): Abbott Vascular,: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Boston Scientific Corporation: Consulting Fees (e.g., advisory boards) (Ongoing); Cordis Corporation: Consulting Fees (e.g., advisory boards) (Ongoing); CorFlow Therapeutics: Consulting Fees (e.g., advisory boards) (Ongoing); Edward Lifesciences: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Lifelens LLC: Consulting Fees (e.g., advisory boards) (Ongoing), Stock Options [in privately held companies] (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Philips: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Siemens: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); W. L. Gore and Associates, Inc.: Consulting Fees (e.g., advisory boards) (Ongoing)